Overview
Balance Sheet
Cash Flow
Growth Analysis
2023
2022
Profitability Metrics
Gross Margin
100.00%
Operating Margin
13.91%
Net Margin
18.47%
Efficiency Metrics
Revenue per Expense Ratio
1.00
R&D as % of Revenue
0.00%
Earnings Quality
EBITDA Margin
14.66%
Income Tax Rate
-32.81%
EPS
$0.00
Balance Sheet Analysis
Current Ratio
8.48
Cash Ratio
3.71
Working Capital
$10.60B
Debt to Equity
0.13
Debt to Assets
2.54%
Equity Ratio
19.10%
Cash Flow Analysis
Operating Cash Flow Ratio
11.22%
Free Cash Flow Ratio
10.91%
CapEx to Revenue
0.31%
Dividends Paid
$90.20M
Stock Buybacks
No buybacks
Total Shareholder Returns
$90.20M
Cash Position Change
7.18%
Key Takeaways (2023 FY)
Maintained positive net income growth despite revenue changes
Detailed Growth Metrics
Core Performance
Revenue
9.86%
Net Income
946.38%
EPS
0.00%
Operating Income
1,197.00%
Operational Efficiency
R&D Expenses
0.00%
SG&A Expenses
30.30%
Operating Cash Flow
690.36%
Free Cash Flow
674.18%
Balance Sheet Health
Assets
0.45%
Debt
28.74%
Book Value per Share
0.00%
Inventory
0.00%
Shareholder Returns
Dividends per Share
0.00%
Shares Outstanding
0.00%
Long Term Trends
3Y Revenue/Share
0.00%
5Y Revenue/Share
-100.00%
3Y Dividend/Share
0.00%
5Y Dividend/Share
0.00%